Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002244:Carbon; D005260:Female; D005354:Fibrosarcoma / Q000276:immunology / Q000628:therapy*; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008623:Mercaptoethanol / Q000494:pharmacology; D051379:Mice; D008808:Mice, Inbred CBA; D010587:Phagocytosis; D011425:Propionibacterium acnes / Q000276:immunology*; D012513:Sarcoma, Experimental / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D008623:Mercaptoethanol; D002244:Carbon